CorVel Corp. 10-Q Summary: Quarter Ended June 30, 2002
Business Context and Reporting Period
This Form 10-Q covers the three-month period ended June 30, 2002, for CorVel Corporation, a provider of workers' compensation managed care services. The company operates in the medical review, patient management, and provider program sectors. As of June 30, 2002, the company had 10,815,000 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 FY2003 (Ended June 30, 2002) | Q1 FY2002 (Ended June 30, 2001) |
|---|---|---|
| Revenues | $66,301,000 | $58,001,000 |
| Gross Profit | $12,310,000 | $10,364,000 |
| Gross Margin | 18.6% | 17.9% |
| Net Income | $4,029,000 | $3,593,000 |
| Diluted EPS | $0.36 | $0.31 |
| Cash from Operations | $4,204,000 | $5,606,000 |
| Cash and Equivalents (End of Period) | $8,468,000 | $9,507,000 |
| Total Assets | $87,676,000 | $80,295,000 (Mar 31, 2002) |
| Current Liabilities | $21,503,000 | $15,637,000 (Mar 31, 2002) |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 14% ($8.3 million) year-over-year. This was driven by a 23% increase in provider program revenues and a 6% increase in patient management revenues.
- Margin Expansion: Gross profit margin improved to 18.6% from 17.9%, attributed to a higher mix of bill review and PPO business, which carry higher margins than patient management services.
- Expense Increase: General and administrative expenses rose to $5.8 million (8.8% of revenue) from $4.6 million (7.9% of revenue), due to increased MIS support, electronic data interface capabilities, and marketing expenses.
- Liquidity Impact: Cash and cash equivalents decreased by $4.1 million to $8.5 million. Net working capital declined by $3.3 million. This reduction was primarily due to the acquisition of AnciCare, $3.3 million in stock repurchases, and an increase in accounts receivable days sales outstanding.
Guidance, Outlook, and Risks
Management Commentary and Strategy:
- Acquisition: On May 16, 2002, CorVel acquired AnciCare, PPO, Inc., a Florida-based diagnostic imaging provider, to expand its CorCare PPO network. The down payment was funded from cash on hand, with potential additional earn-out payments contingent on performance.
- Share Repurchases: The Board approved a 1,000,000 share expansion to its repurchase plan. During the quarter, the company repurchased 97,000 shares for $3.3 million. Cumulative repurchases since 1996 total 4.9 million shares for $72.4 million.
- Outlook: Management believes current cash balances and anticipated internally generated funds are sufficient to meet requirements for the next twelve months. No specific numerical guidance for future periods was provided in this filing.
Risks and Contingencies:
- Regulatory Environment: The company faces evolving state and federal regulations regarding medical review licensing and managed care networks, which could increase operational costs.
- Competition: Competition is intensifying from large insurers, HMOs, and PPOs, particularly as legislation allows employers to designate health plans for workers' compensation claims.
- Market Dynamics: Declines in workers' compensation claims and costs in certain states could adversely affect demand for the company's services.
- Legal Liability: While the company does not practice medicine, it faces potential litigation regarding medical treatment recommendations and claims management.
Investor Verification Checklist
- Verify the integration progress and financial performance of the AnciCare acquisition.
- Monitor the trend in days sales outstanding (DSO) given the recent increase in accounts receivable.
- Assess the impact of state-specific regulatory changes on licensing costs and operational scope.
- Review the sustainability of the gross margin expansion as the company shifts revenue mix toward higher-margin PPO services.
- Confirm the status of the expanded stock repurchase program and its impact on future cash flow.